Inactive Instrument

All News Curis, Inc. Nasdaq

Equities

Curis : FIFTH AMENDED AND RESTATED2010 STOCK INCENTIVE PLAN - Form 8-K	24/05	PU
Transcript : Curis, Inc. - Special Call	15/05
Curis Announces Additional Data from TakeAim Leukemia Study	15/05	PR
Curis, Inc. Announces Additional Data from Take Aim Leukemia Study	15/05	CI
Curis to Present Updated Data from the TakeAim Leukemia Study	13/05	AQ
Curis to Present Updated Data from the TakeAim Leukemia Study	10/05	PR
Curis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Transcript : Curis, Inc., Q1 2024 Earnings Call, May 07, 2024	07/05
Earnings Flash (CRIS) CURIS Reports Q1 Revenue $2.1M, vs. Street Est of $2M	07/05	MT
Curis: Q1 Earnings Snapshot	07/05	AQ
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024	30/04	PR
Curis Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	08/04	AQ
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/04	PR
Curis to Present at Upcoming Healthcare Conferences in April	04/04	PR
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)	02/04	PR
HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating	09/02	MT
Curis Provides Fourth Quarter 2023 Business Update	09/02	AQ
Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
Transcript : Curis, Inc., Q4 2023 Earnings Call, Feb 08, 2024	08/02
Curis: Q4 Earnings Snapshot	08/02	AQ

No results for this search